A Saxenda app that understands a daily injection

Steadyway is an iPhone app for people on Saxenda: a daily injection schedule, the 0.6 to 3 mg titration, site rotation that matters far more at seven shots a week, and the weight trend behind it.

Yes — Steadyway, and it treats a daily injection as a daily injection rather than as a weekly one with the numbers changed. The interval comes from the medication you pick, so the reminders, the streak, the titration chart and the supply count all work in days.

Doses 0.6, 1.2, 1.8, 2.4 and 3 mg
Taken as Daily injection, liraglutide
Licensed for Weight management (UK, EU, US)
Out of the fridge 30 days once in use
Missed a dose Skip it and take the next one at your usual time. Never double up, and if you miss more than three days in a row your dose may need restarting lower — ask your prescriber.

Most GLP-1 trackers assume a weekly shot

That assumption is everywhere, and it breaks quietly. A weekly reminder on a daily medication is useless. An adherence figure calculated against 52 doses a year is wrong by a factor of seven. A supply count that thinks a pen is four doses has no idea when you run out. Steadyway asks which medication you are on during setup and everything downstream follows from the answer.

Site rotation matters far more at seven a week

Weekly injectors can be casual about rotation and mostly get away with it. Seven injections a week into the same handful of square centimetres is how people end up with lumps and absorption that stops being predictable. The app shows six sites with the date each last came round and suggests the one that has rested longest — which is a much more useful feature here than it is on Mounjaro.

The 0.6 to 3 mg climb

Saxenda steps up weekly through five rungs to 3 mg, which means the first month is a new dose every seven days while you are also learning to inject daily. The titration chart shows where you are and how long you have been there, and the app never suggests the next step — that is your prescriber's.

Missing days, honestly

A missed day is logged as missed rather than quietly forgotten, and your streak stays attached to logging rather than to a perfect record — because a streak that breaks on a bad day is a streak that makes bad days worse.

Saxenda has no catch-up dose: you take the next one at the usual time. Missing more than about three days running can mean restarting lower and titrating back up, because tolerance to the side effects fades faster than people expect. The app will show you the gap; the decision is your prescriber's.

From Steadyway

Setup is today's weight, your current dose, and the time you inject — the time, not the day, because on Saxenda that is the part worth remembering.

Quiet hours hold back everything except the dose reminder itself, which is the one that cannot wait until morning.

Common questions

Most GLP-1 trackers assume a weekly shot. Does this one?
No. The interval comes from the medication you pick, so Saxenda is a daily schedule throughout — the reminders, the adherence streak, the titration chart and the supply count all work in days rather than weeks.
Does site rotation matter more on a daily injection?
Considerably. Seven injections a week into the same area is how people end up with lumps and unreliable absorption. The app shows six sites with the date each last came round and suggests the one that has rested longest.
What happens if I miss a day?
It is logged as missed, not quietly forgotten, and your streak stays attached to logging rather than to a perfect record. Saxenda has no catch-up dose — you take the next one at the usual time — and missing more than three days running is a conversation with your prescriber about restarting lower.
Does it track how long the pen has been in use?
Yes — one month below 30 °C or in the fridge, counted from the day you say it came out, with a nudge before the window closes rather than after.

Read next

Steadyway is a tracker, not a medical device, and nothing on this page is medical advice. Decisions about your dose or your treatment belong with the person who prescribed it. See the medical disclaimer.

Not affiliated with, endorsed by, or connected to Eli Lilly and Company. Mounjaro and Zepbound are their trade marks. Last updated 8 September 2026.